Morgan Stanley Renovacor, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.12 - $2.18 $276 - $5,031	2,308 Added 4.35%	55,329 $139,000
Q2 2022 Oct 27, 2022	SELL	$1.56 - $4.29 $21 - $60	-14 Reduced 0.03%	53,021 $108,000
Q2 2022 Aug 15, 2022	SELL	$1.56 - $4.29 $21 - $60	-14 Reduced 0.03%	53,021 $108,000
Q1 2022 Oct 27, 2022	BUY	$4.02 - $8.23 $56 - $115	14 Added 0.03%	53,035 $225,000
Q4 2021 Feb 14, 2022	BUY	$6.99 - $9.39 $12,917 - $17,352	1,848 Added 3.61%	53,035 $408,000
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $395,675 - $545,141	51,187 New	51,187 $463,000

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.